Valproic acid toxicity occurs when levels of this seizure and mood-stabilizing medication build up to dangerous concentrations in the body. The normal therapeutic range is 50 to 100 mcg/mL in blood, and toxicity typically begins when levels climb above 100 mcg/mL. At concentrations of 180 mcg/mL or higher, serious neurological symptoms are common. Toxicity can happen from a single large overdose, a gradual buildup over weeks or months, or drug interactions that raise blood levels unexpectedly.
How Toxicity Develops
Valproic acid is prescribed under several brand names for epilepsy, bipolar disorder, and migraine prevention. At therapeutic doses, the drug works partly by boosting a calming brain chemical called GABA. But when levels get too high, the drug starts interfering with critical processes in the liver and brain.
One of the most important effects is on the urea cycle, the body’s system for clearing ammonia. Valproic acid blocks an enzyme called carbamoyl phosphate synthetase I, which kicks off the first step of ammonia removal. When this enzyme is suppressed, ammonia accumulates in the blood even though the liver itself may not be damaged. This is why ammonia levels can spike dangerously while standard liver tests come back completely normal, a combination that can mislead both patients and clinicians.
Large doses also disrupt how cells burn fat for energy, which can lead to a buildup of acid in the blood (metabolic acidosis) and, in severe cases, liver failure.
Symptoms of Acute Overdose
An acute overdose, generally defined as ingesting more than 200 mg per kilogram of body weight, produces symptoms across multiple organ systems. Early signs are often gastrointestinal: nausea, vomiting, diarrhea, and abdominal pain. These can appear within hours of ingestion.
Neurological symptoms follow as blood levels rise. Tremors, agitation, and constricted pupils are common. As toxicity worsens, confusion, extreme drowsiness, and seizures may develop. In severe cases, this progresses to coma. Heart rate often increases while blood pressure drops, and breathing can become dangerously slow or shallow.
The most life-threatening features of a severe overdose include:
- Hyperammonemic encephalopathy: brain swelling and dysfunction caused by ammonia buildup, potentially leading to coma and death
- Cerebral edema: dangerous swelling of brain tissue
- Metabolic acidosis: a shift in blood chemistry that strains the heart and other organs
- Cardiovascular collapse: severely low blood pressure and rapid heart rate
Chronic Toxicity Looks Different
You don’t need to take a massive single dose to develop toxicity. Chronic toxicity builds up over days to weeks, often in people taking their prescribed dose. This can happen when kidney or liver function declines, when another medication interferes with how the body clears valproic acid, or when the “free” (unbound) fraction of the drug in the blood increases.
Chronic toxicity tends to present more subtly. The hallmark is rising ammonia levels that cause progressive confusion, personality changes, or new-onset seizures in someone who was previously stable. Because liver enzymes often remain normal, the connection to valproic acid can be missed for days. Weight gain, hair thinning, and a persistent tremor at therapeutic levels can also signal that the drug is accumulating. In its most dangerous form, chronic toxicity causes life-threatening hyperammonemia and liver damage.
Free valproic acid concentration matters more than total levels in predicting problems. Research has shown that free levels above roughly 8.6 mcg/mL increase the risk of hyperammonemia, and levels above about 14.7 mcg/mL significantly raise the risk of low platelet counts, which can cause abnormal bleeding.
What Happens at the Hospital
When toxicity is suspected, a blood level of valproic acid is drawn, but that number alone doesn’t tell the full story. Ammonia is measured separately because it doesn’t always track with the drug level. A person can have a moderately elevated valproic acid level and a critically high ammonia level, or vice versa. Blood sugar, electrolytes (including calcium, magnesium, and phosphorus), liver function, lactate, and blood gas analysis are all checked. Levels are typically rechecked every two to four hours initially.
Lab results in significant toxicity often show a characteristic pattern: high sodium, low calcium, elevated acid levels with a widened anion gap, high blood concentration (hyperosmolality), and elevated ammonia. This combination, especially when paired with altered consciousness, points strongly toward valproic acid as the cause.
Treatment and Recovery
There is no single antidote that instantly reverses valproic acid toxicity, but L-carnitine is the closest thing to one. Carnitine is a natural compound the body uses to transport fats into cells for energy. Valproic acid depletes carnitine stores, and replacing it intravenously helps restore normal ammonia processing and protects the liver. Current pharmacokinetic research supports giving an intravenous loading dose followed by a continuous infusion rather than repeated individual doses.
Lactulose, the same medication used for liver disease, is given to pull ammonia out of the body through the gut. Activated charcoal may be used if someone arrives at the hospital within an hour or two of ingestion, though it becomes less effective as time passes.
For the most severe cases, hemodialysis can physically filter valproic acid out of the blood. Dialysis is typically considered when blood levels exceed 700 mcg/mL, when someone is in a coma that isn’t improving, when there are signs of liver failure, or when the body appears to still be absorbing the drug despite other treatments. Beyond dialysis, treatment is supportive: mechanical breathing assistance if respiration is depressed, fluids and medications to maintain blood pressure, and close monitoring in an intensive care unit.
Recovery Timeline and What to Expect
For mild to moderate toxicity caught early, symptoms often begin improving within 24 to 48 hours as the body clears the drug and ammonia levels normalize. People treated with L-carnitine for hyperammonemic encephalopathy frequently show noticeable improvement in alertness within hours of the infusion starting.
Severe overdoses with coma, cerebral edema, or multi-organ involvement have a much longer and less predictable course. Recovery can take days to weeks in an intensive care setting, and neurological damage from prolonged high ammonia levels or brain swelling may not fully reverse. The prognosis depends heavily on how high ammonia levels climbed, how long the brain was exposed, and how quickly treatment began.
For people who developed chronic toxicity on a prescribed dose, the medication is either stopped entirely or the dose is significantly reduced. Ammonia levels and symptoms are monitored until they normalize, and the prescribing plan is reassessed. In many cases, an alternative medication is chosen going forward.
Risk Factors Worth Knowing
Certain groups face higher risk. Children under two years old are more vulnerable to the liver-damaging effects of valproic acid. People with inherited urea cycle disorders, even undiagnosed ones, can develop severe hyperammonemia at normal therapeutic doses. Those taking multiple seizure medications, particularly other drugs processed by the liver, are at increased risk because of drug interactions that raise free valproic acid levels.
Low albumin levels (common in older adults, people with liver disease, and those who are malnourished) also increase risk. Valproic acid normally binds tightly to albumin in the blood, and when albumin is low, more of the drug circulates in its active, unbound form. This means the total blood level can appear normal while the amount actually affecting the brain and liver is dangerously high.